All Episodes

Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma

SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology

SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology

CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma

Hot Topics: What's next in neuro-oncology

Neuro-Oncology Nugget: Career Development Outreach from SNO

Neuro-onc Narratives: An Interview with Caroline Catlin

Author Interview: "DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma"

Hot Topics: AYA in Neuro-Oncology

Neuro-Oncology Nugget: Bivalent EGFR/IL13Rα2 CAR T Cells for Recurrent Glioblastoma

SNObound: Career Advice from Dr. Brooke Braman in Radiation Oncology

Author Interview: Global analysis of clinical trials for children and adolescents with CNS tumors

Neuro-Oncology Nugget: Intracerebroventricular B7-H3 CAR T Cells for DIPG

Neuro-onc Narratives: Advocating for patient well-being in neuro-oncology

Author Interview: Visual morbidity, long-term outcome, and prognostic factors in infants and young children with optic pathway low-grade glioma

Hot Topics: Clinician-Patient Relationship in Neuro-Oncology

Neuro-Oncology Nugget: Targeted Radiotherapy Using Rhenium-186 Nanoliposomes for Recurrent Glioma

SNObound: Career Advice from Dr. Gelareh Zadeh

Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma

Hot Topics: Radiation Hypofractionation in Glioma

Neuro-Oncology Nugget: Targeting CDK8 in MYC-Driven Medulloblastoma

Neuro-Onc Narratives: Patient Services at the American Brain Tumor Association

Author Interview: Post-irradiation chemotherapy in patients with newly diagnosed ependymoma

Hot Topics: How longitudinal profiling of glioma informs therapy development

Neuro-oncology Nugget: Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma

SNObound: Career Advice from Neuro-oncologist, Dr. Lisa DeAngelis

Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas

Introduction to Neuro-Oncology: The Podcast 2.0

Radiotherapy induced neurocognitive decline

QOL and cognitive functioning in patients with oligodendroglioma

Post-operative radiation in recurrent grade 1 meningiomas

mRNA CAR T against GD2 in high-grade glioma models

A transcriptomic atlas of CNS tumors

Gut microbiome in primary CNS lymphoma

Germline analysis of diffuse midline glioma

The proteomic landscape of diffuse midline glioma

Radio-Pathomic maps and MR perfusion

CSF proteomics in glioma

Vorasidenib in IDH mutant glioma

KL-50 in post TMZ MMR-deficient GBM

Measurable disease per FET-PET vs MRI in GBM

Pre-radiation chemotherapy in GBM

cIMPACT-NOW Update 8: grading of meningiomas

Residual tumor volume and survival after CCNU/TMZ in GBM

Alterations in RNA splicing between meningioma DNA methylation groups

The immune landscape of IDH mutant and IDHwt glioma

Equity-driven applications of AI in neuro-oncology

IDH mutant glioma across age groups

Contemporary molecular prognostic signatures in glioma

FDG PET in PCNSL

TMZ and MGMT in elderly GBM patients

IDH mutant glioma and IDH inhibitors

Leptomeningeal disease, a SNO and ASCO review

Cancer stems cell in GBM

Drug delivery across the blood-brain barrier

Gliomatosis cerebri in children

Immunotherapy drives mesenchymal shift in GBM

Long-term outcomes of pediatric patients with optic pathway glioma

NF1 mutation and neuronal hyperexcitability

Postoperative cerebellar mutism

Cell cycle checkpoints and alkylating agents

Liquid biopsy in CNS lymphoma

Immunotherapy for glioblastoma, lessons learned

TERTp mutation clonality in glioma

Liquid biopsy in H3K27M glioma

Glioma genetic profiles and electrophysiologic hyperexcitability

Epidemiology of glioma in Belgium

The Biology of H3K27M Mutant Gliomas

3D tumor volume assessment in PCNSL

Brain-tumor related epilepsy; a SNO consensus review

Vorasidenib and grading of IDH mutant astrocytoma

Insulin feedback and PI3K inhibition in GBM

SOX10 indel mutations in schwannomas

Dendritic cell vaccines in gliomas

Intrathecal trastuzumab for leptomeningeal metastases

Short term topiramate for radiation induced cytotoxic edema

Venous thromboembolism in gliomas

RANO resect

Methylation profiling of adult ependymoma

Pseudoprogression in IDH-mutant high-grade gliomas

Changes in survival outcomes in melanoma patients with brain metastases

Radiation therapy and structural brain changes

Objective response rate targets for recurrent glioblastoma clinical trials

Mitotic count prognostic significance in IDH-mutant astrocytoma in the molecular era

Palliative care in neuro-oncology

Nivolumab in MGMT methylated GBM

IDH mutant gliomas; SNO consensus Review

DNA methylation subclass and extent of GBM resection

Pre-operative [11C]methionine PET for low-grade glioma

The role of T lymphocytes in the glioma pathobiology

CDKN2A homozygous deletion in IDH mutant astrocytoma

EGFR: the lazarus target in glioblastom

Brain metastases; a SNO consensus review: Part 2

Brain metastases; a SNO consensus review: Part 1

Pediatric IDH mutant gliomas

Low-risk meningioma: Outcomes from NRG 0539

Selumetinib in children with NF1 and plexiform neurofibroma

Targeted therapy for BRAF-mutant pediatric glioma

Early/evolving IDH wild-type glioblastoma

PI3K signaling in IDH mutant gliomas

Cell-free DNA from CSF in pediatric, adolescent and young adult patients

Molecular determinants of neurocognitive deficits in glioma

H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

Clinical trial accrual for women and minorities in neuro-oncology

The clinical utility of next generation sequencing for IDHwt glioblastoma

Trabectedin for recurrent grade 2 or 3 meningiomas

Glioblastoma cell heterogeneity and plasticity

Moleculary integrated grading for meningioma

BOLD fMRI in IDH mutant gliomas

Glioblastoma subtypes and response to Dasatinib

Resection for recurrent brain metastases

Incidental Meningiomas

Immunosuppression in IDH mutant gliomas

Immunotherapy for melanoma brain metastases

DNA methylation profiles within the CATNON trial

18F FET PET in childhood CNS tumors

Checkpoint blockade in atypical meningiomas

Molecular signatures of glioma causation

Testing methods for MGMT promoter methylation

Temozolomide-induced hypermutation in IDH-mutant low-grade gliomas

Posterior fossa syndrome

Loss of H3K27me3 in meningiomas

Loss of H3K27me3 in the Tübingen meningioma cohort

A prospective phase II randomized trial of proton radiotherapy vs intensity modulated radiotherapy for patients with newly diagnosed GBM

Brain radiotherapy and decline in fine motor skills

A serum based DNA methylation assay to detect gliomas

PTEN deficiency and proteosome addiction in glioblastoma

Cold-Inducible RNA-Binding Protein expression and recurrence of brain metastases

The incidence of brain metastases among patients with metastatic breast cancer

Epidemiology of Brainstem High-Grade Gliomas in Children and Adolescents in the United States, 2000-2017

A large longitudinal study of patients with Neurofibromatosis Type 2.

Vorinostat and bevacizumab for recurrent glioblastoma

A subset of pediatric thalamic gliomas

Supratotal resection of lower-grade gliomas

Friends of SNO

Announcing Neuro-Oncology: The Podcast